Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Acetaminophen resolution

This article was originally published in The Tan Sheet

Executive Summary

Group also resolves to support legislation to "require, on a national level, enhanced package warning labels on acetaminophen-containing products warning patients that liver failure can result from taking the product in combination with even moderate amounts of alcohol or from taking the product in dosages greater than advised in instructions." AMA also reiterated its call to ban sale of ephedra supplements in the U.S. (1"The Tan Sheet" Feb. 18, 2002, In Brief)...

Related Content

Maves’ change of heart on ephedra





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts